US Capital Engaged on $2M Convertible Debt Financing for Provia Laboratories, LLC.

US Capital Engaged on $2M Convertible Debt Financing for Provia Laboratories, LLC.

ProviaLabssquare21US Capital Partners Inc. has been engaged by Grace Century project partner Provia Laboratories, LLC (“Provia”) as its strategic advisor for a $2 million convertible debt financing. Provia will use the new financing to expand sales and marketing activities, retire existing debt, and provide general working capital as the business continues to grow.

Grace Century CEO Scott Wolf said “We are thrilled to announce that the company U.S. Capital Partners will be spearheading the future funding for our Portfolio project, Provia labs. This officially closes our promotional involvement as of Wednesday, February 15, 2017.”

US Capital Partners Inc. is a private investment bank headquartered in San Francisco. Through its affiliate broker dealer, US Capital Global Securities, LLC, the firm facilitates equity private placements, makes direct debt investments, participates in debt facilities, and has a wide distribution for these services and financial products for small and medium-sized businesses.

“We are extremely pleased to be assisting Provia with its business financing needs in a strategic investment banking role, as the company moves into the next phase of its business expansion,” said Jeffrey Sweeney, Chairman and CEO at US Capital Partners. “The opportunity to participate in Provia’s $2 million convertible debt financing raise is now open to eligible investors through our digital investment platform, available at www.uscgs.com, which offers a curated selection of private placement opportunities.”

“At the core of Provia’s vision, we believe in helping individuals benefit from their own cells,” said Howard Greenman, CEO at Provia. “Store-A-Tooth offers one of the few opportunities we have as parents to collect and preserve our children’s stem cells when our children are young, and their cells are healthy. We have prepared our business to scale, and plan to work nationally with dental and oral surgery offices, expand our direct-to-consumer activities, and bring our technology to additional markets through strategic partnerships.”